These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of stage I germ cell tumors of the testis].
    Author: Santomé Couto L, Tabernero Caturla JM, Villavicencio Mavrich H, Valentí Moreno V.
    Journal: Arch Esp Urol; 2000; 53(6):474-86. PubMed ID: 11002515.
    Abstract:
    OBJECTIVE: To review the advantages, disadvantages and efficacy of the different therapeutic options for stage I seminoma and nonseminomatous germ cell testicular tumors. METHODS: The literature on the treatment of stage I germ cell testicular tumors was reviewed. RESULTS/CONCLUSIONS: Germ cell tumors of the testis constitute 1-1.5% of neoplasms in the male, accounting for 95% of testicular neoplasms, and is the most common solid tumor in men aged 20-35 years. Currently, 70% of the patients with seminoma and 50% of the patients with nonseminomatous germ cell testicular tumors are diagnosed in stage I. Radiotherapy following orchidectomy has classically been utilized in the treatment of stage I germ cell testicular tumors. Postoperative radiation therapy is currently being replaced by close patient follow-up in many centers. Retroperitoneal lymphadenectomy post-orchidectomy is the standard treatment for stage I nonseminomatous germ cell testicular tumors. Today, however, the foregoing approach is also being replaced by close postoperative follow-up.
    [Abstract] [Full Text] [Related] [New Search]